Get the tools used by (smart)² investors.

SP500 -4.8%DOW -4.0%FTSE 100 -1.5%NIKKEI -2.8%OIL -7.1%GOLD -0.6%

Watchlists Ideas Screener Data Explorer Charts Saved Work

AFFO Growth Forecast for Mayne Pharma Group Limited

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

MAYN.F: Mayne Pharma Group Limited

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, a...

4.38 USD

Price

– USD

Fair Value

–

Upside

2.42 - 4.60

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on Mayne Pharma Group Limited's AFFO Growth Forecast:

Performance Summary

Affo growth forecast for Mayne Pharma is not meaningful.

Benchmarks

Metric Usage: AFFO Growth Forecast

Hide this widget

affo_proj_growth

Slug

number

Datatype

text

Format

current

Default Period

FY, Q

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to AFFO Growth Forecast in the growth category include:

Net Income Forecast CAGR (2y) - Two year compound annual growth rate in forecasted net income.
Capital Expenditures CAGR (3y) - Three-year compound annual growth rate in capital expenditures.
Cost of Revenue CAGR (7y) - Seven-year compound annual growth rate in cost of revenue.
Preferred Dividends Paid CAGR (5y) - Five-year compound annual growth rate in preferred dividends & other adj.

View Full List

Search for metric or datapoint

AFFO Growth Forecast

Period over prior period growth in forecasted adjusted funds from operations.

Definition of AFFO Growth Forecast

Hide this widget

Period over prior period growth in forecasted adjusted funds from operations.

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

No data available